Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenberg, R. N.
Right arrow Articles by Nyhan, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, R. N.
Right arrow Articles by Nyhan, W. L.
NEUROLOGY 1979;29:917
© 1979 American Academy of Neurology

Joseph disease

Protein patterns in fibroblasts and brain

Roger N. Rosenberg, M.D., Leigh Thomas, B.S., Fred Baskin, Ph. D., Joel Kirkpatrick, M.D., Carolyn Bay, M.S. and William L. Nyhan, M.D., Ph.D.

Laboratory of Cellular Neurobiology, Department of Neurology and Department of Pathology, The University of Texas Health Science Center at Dallas, Dallas, Texas (Drs. Rosenberg, Baskin, and Kirkpatrick and Ms Thomas); and the Department of Pediatrics, University of California, San Diego, San Diego, California (Ms. Bay and Dr. Nyhan).

The separation of brain and fibroblast proteins was analyzed on two-dimensional acrylamide gels. Proteins were examined from skin fibroblast cultures and brain homogenates from the frontal cerebral cortex, putamen, and cerebellum. Protein species from skin fibroblast cultures of controls and patients with Joseph disease or Huntington disease were not significantly different. The proteins from homogenates of the cerebral cortex, putamen, and cerebellum from controls differed from those of one Joseph disease patient. Two major classes of proteins were increased in the patient's putamen and cerebellum. Proteins of 40,000 and 50,000 daltons-including the glial filamentous acidic protein complex (molecular weight 50,000), and two proteins which migrated near actin-were increased in the cerebellum. The glial filamentous acidic protein complex increased 3.7-fold in the putamen of the patient. These protein changes probably represent gliosis, but may also be an expression of the primary genetic mutation.




This article has been cited by other articles:


Home page
BrainHome page
U. Rub, D. Del Turco, K. Del Tredici, R. A. I. de Vos, E. R. Brunt, G. Reifenberger, C. Seifried, C. Schultz, G. Auburger, and H. Braak
Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance
Brain, October 1, 2003; 126(10): 2257 - 2272.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. M. Landau, R. E. Schmidt, R. C. McGlennen, and S. G. Reich
Hereditary Spastic Paraplegia and Hereditary Ataxia: Part 2: A Family Demonstrating Various Phenotypic Manifestations With the SCA3 Genotype
Arch Neurol, May 1, 2000; 57(5): 733 - 739.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.